Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (2937)	5/13/2020 2:44:10 PM
From: Miljenko Zuanic	Respond to of 3557

For instance Dupi run much better in AD than in atopic asthma! One have to wonder why?

To: Miljenko Zuanic who wrote (2937)	5/13/2020 5:48:38 PM
From: Felix B	Read Replies (1) \| Respond to of 3557

There is a lot of hype behind it and even if (big IF) not sure how commercial successful it will be. Look how much GILD has been dropping with any announcement they make. Yes Ebola is not corona...how did the MERS ab do?

To: Miljenko Zuanic who wrote (2937)	6/20/2020 11:11:44 AM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 3557

REGN chart (w) for the last 5 years: stockcharts.com (feel necessary data) Obviously I was very wrong with my scepticism about taking out 580-600 level. Consequence, I lost 20% of my REGN holding. From severe negative in Oct-2019 (275) toward fairly positive (one may said extreme positive) 650 level! Maybe, this is all for good..... so I will be more inclined to diversify my investment. I am still very cautious about market and expect significant correction in 4Q-20 time frame, due to COVID19!